Novartis, Microsoft Team to Transform Medicine with AI
October 1, 2019
took an important step in reimagining medicine by founding the Novartis
AI innovation lab and by selecting Microsoft Corp. as its strategic AI
and data-science partner for this effort. The new lab aims to
significantly bolster Novartis AI capabilities from research through
commercialization and help accelerate the discovery and development of
transformative medicines for patients worldwide.
This strategic alliance will focus on two core objectives:
•AI Empowerment. The lab will aim to bring the power of AI to the desktop of every Novartis associate. By bringing together vast amounts of Novartis datasets with Microsoft’s advanced AI solutions, the lab will aim to create new AI models and applications that can augment our associates’ capabilities to take on the next wave of challenges in medicine.
•AI Exploration. The lab will use
the power of AI to tackle some of the hardest computational challenges
within the life sciences, starting with generative chemistry, image
segmentation & analysis for smart and personalized delivery of
therapies, and optimization of cell and gene therapies at scale.
Novartis focuses its efforts around four strategic digital priority areas:
•Scaling 12 digital lighthouse projects: Build a strong foundation and jumpstart digital transformation
•Make Novartis digital: sharing, learning and talent acquisition
•Becoming the #1 partner in the tech ecosystem: bridge Novartis with external expertise
•Bolder moves: lead through future disruptive healthcare scenarios with large-scale partnerships